Gainers
- Avidity Biosciences (NASDAQ:RNA) stock rose 43.7% to $70.63 during Monday's pre-market session. The company's market cap stands at $7.1 billion.
- Dyne Therapeutics (NASDAQ:DYN) shares increased by 37.55% to $23.55. The market value of their outstanding shares is at $2.4 billion.
- Zenas BioPharma (NASDAQ:ZBIO) stock increased by 22.57% to $29.29. The company's market cap stands at $1.1 billion.
- PepGen (NASDAQ:PEPG) shares increased by 17.06% to $5.35. The market value of their outstanding shares is at $314.1 million.
- Neumora Therapeutics (NASDAQ:NMRA) stock increased by 15.63% to $3.04. The company's market cap stands at $425.9 million.
- Semler Scientific (NASDAQ:SMLR) stock rose 14.56% to $27.45. The market value of their outstanding shares is at $362.8 million.
Losers
- Intellia Therapeutics (NASDAQ:NTLA) shares fell 46.9% to $13.6 during Monday's pre-market session. The market value of their outstanding shares is at $2.7 billion.
- Genenta Science (NASDAQ:GNTA) shares decreased by 34.04% to $4.09. The market value of their outstanding shares is at $113.3 million.
- Wellgistics Health (NASDAQ:WGRX) shares fell 30.4% to $0.8. The company's market cap stands at $105.1 million.
- Organon (NYSE:OGN) shares declined by 15.4% to $7.75. The company's market cap stands at $2.3 billion.
- Nanobiotix (NASDAQ:NBTX) stock decreased by 14.8% to $16.36. The market value of their outstanding shares is at $925.7 million.
- Prenetics Global (NASDAQ:PRE) stock fell 14.03% to $14.41. The company's market cap stands at $204.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
GNTAGenenta Science SPA
$2.97-1.33%
NBTXNanobiotix SA
$18.472.67%
NMRANeumora Therapeutics Inc
$2.8815.2%
NTLAIntellia Therapeutics Inc
$12.40-5.49%
OGNOrganon & Co
$6.492.37%
PEPGPepGen Inc
$4.510.04%
PREPrenetics Global Ltd
$14.797.02%
RNAAvidity Biosciences Inc
$69.790.20%
SMLRSemler Scientific Inc
$25.33-2.54%
WGRXWellgistics Health Inc
$0.67708.48%
ZBIOZenas BioPharma Inc
$29.445.11%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
